Buthionine Sulphoximine

丁磺氨酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameButhionine Sulphoximine
Drug Alias NameNSC-326231BSO
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionGamma-glutamylcysteine synthetase inhibitors
TargetsGamma-glutamylcysteine synthetase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsBreast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaPending
Originator CompaniesNational Cancer InstituteLiaoning Lantian Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteInstitute Of Radiation Medicine, Fudan UniversityZhongmin New Technology Co Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsBreast Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksWikipedia